Skip to main content
Log in

Association of Copper and Zinc Intake with Inflammatory Bowel Disease and Fecal Incontinence Symptoms: Evidence from the National Health and Nutrition Examination Survey

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

The associations between copper and zinc intake with the risk of inflammatory bowel disease (IBD) and fecal incontinence symptoms in the general population are not well understood. This study aims to evaluate the associations of zinc and copper intake with the risk of IBD and fecal incontinence symptoms in adults aged ≥ 20 years using data from the 2009–2010 National Health and Nutritional Examination Surveys (NHANES) (N = 5593). The presence of IBD was analyzed from the NHANES data, directly querying the presence or absence of ulcerative colitis (UC) and Crohn’s disease (CD). Fecal incontinence symptoms including accidental bowel leakage of gas, mucus, liquid, or solid stool were determined by using the bowel health questionnaire. Multivariable logistic regressions models were performed controlling for confounding factors (dietary, lifestyle, psychological, and health conditions). No associations between either zinc or copper intake with IBD were found. However, zinc intake was independently associated with increased risk of bowel leakage of gas or liquid. Compared with quartile 1, the multivariate-adjusted ORs (95%CI) of bowel leakage of gas across quartiles 2–4 of zinc intake were 1.41 (1.15–1.71), 1.30 (1.00–1.68), and 1.61 (1.16–2.23). Likewise, there was a trend for higher odds of bowel leakage of liquid among participants in the higher zinc intake. Compared with quartile 1, the multivariate-adjusted ORs (95%CI) of bowel leakage of liquid across quartiles 2–4 of zinc intake were 3.55 (0.94–13.41), 3.65 (1.27–10.47), and 5.06 (1.25–20.50). Future prospective studies are warranted to confirm these findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142:46–54 e30

    Article  Google Scholar 

  2. Zand A, van Deen WK, Inserra EK, Hall L, Kane E, Centeno A, Choi JM, Ha CY, Esrailian E, D’Haens GR, Hommes DW (2015) Presenteeism in inflammatory bowel diseases: a hidden problem with significant economic impact. Inflamm Bowel Dis 21:1623–1630

    Article  Google Scholar 

  3. Clara Abraham MD, Judy H. Cho MD (2009) Inflammatory bowel disease. N Engl J Med 2066–2078

  4. Kaplan GG, Ng SC (2017) Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology 152:313–321

    Article  Google Scholar 

  5. Phillips CM, Chen LW, Heude B, Bernard JY, Harvey NC, Duijts L, Mensink-Bout SM, Polanska K, Mancano G, Suderman M, Shivappa N, Hébert JR (2019) Dietary inflammatory index and non-communicable disease risk: a narrative review. Nutrients 11

  6. Gammoh NZ, Rink L (2017) Zinc in infection and inflammation. Nutrients 9

  7. Lewandowski Ł, Kepinska M, Milnerowicz H (2019) The copper-zinc superoxide dismutase activity in selected diseases. Eur J Clin Invest 49:e13036

    Article  Google Scholar 

  8. Mohammadi E, Qujeq D, Taheri H, Hajian-Tilaki K (2017) Evaluation of serum trace element levels and superoxide dismutase activity in patients with inflammatory bowel disease: translating basic research into clinical application. Biol Trace Elem Res 177:235–240

    Article  CAS  Google Scholar 

  9. Stochel-Gaudyn A, Fyderek K, Kościelniak P (2019) Serum trace elements profile in the pediatric inflammatory bowel disease progress evaluation. J Trace Elem Med Biol 55:121–126

    Article  CAS  Google Scholar 

  10. Weng YJ, Gan HY, Li X, Huang Y, Li ZC, Deng HM, Chen SZ, Zhou Y, Wang LS, Han YP, Tan YF, Song YJ, du ZM, Liu YY, Wang Y, Qin N, Bai Y, Yang RF, Bi YJ, Zhi FC (2019) Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease. J Dig Dis 20:447–459

    Article  CAS  Google Scholar 

  11. Rogler G, Vavricka S, (2015) Exposome in IBD: recent insights in environmental factors that influence the onset and course of IBD. Inflamm Bowel Dis 21:400–408

  12. Bhandari S, Larson ME, Kumar N, Stein D (2017) Association of inflammatory bowel disease (ibd) with depressive symptoms in the united states population and independent predictors of depressive symptoms in an ibd population: a NHANES study. Gut Liver 11:512–519

    Article  Google Scholar 

  13. de Silva PS, Yang X, Korzenik JR, Goldman RH, Arheart KL, Caban-Martinez AJ (2017) Association of urinary phenolic compounds, inflammatory bowel disease and chronic diarrheal symptoms: Evidence from the National Health and Nutrition Examination Survey. Environ Pollut 229:621–626

  14. Opstelten JL, Leenders M, Dik VK, Chan SS, van Schaik FD, Khaw KT, Luben R, Hallmans G, Karling P, Lindgren S, et al (2016) Dairy products, dietary calcium, and risk of inflammatory bowel disease: results from a european prospective cohort investigation. Inflamm Bowel Dis 22:1403–1411

  15. International Diabetes Federation Guideline Development Group. (2014) Global guideline for type 2 diabetes. Diabetes Res Clin Pract 104:1–52

  16. Whelton PK, Carey RM, Aronow WS, Casey DJ, Collins KJ, Dennison HC, DePalma SM, Gidding S, Jamerson KA, Jones DW, et al (2018) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 71:2199–2269

  17. Ballou S, Singh P, Rangan V, Iturrino J, Nee J, Lembo A (2019) Obesity is associated with significantly increased risk for diarrhoea after controlling for demographic, dietary and medical factors: a cross-sectional analysis of the 2009-2010 National Health and Nutrition Examination Survey. Aliment Pharmacol Ther 50:1019–1024

  18. Chasapis CT, Ntoupa PA, Spiliopoulou CA, Stefanidou ME (2020) Recent aspects of the effects of zinc on human health. Arch Toxicol 94:1443–1460

  19. Ringstad J, Kildebo S, Thomassen Y (1993) Serum selenium, copper, and zinc concentrations in Crohn's disease and ulcerative colitis. Scand J Gastroenterol 28:605–608

  20. Scrimgeour AG, Lukaski HC (2008) Zinc and diarrheal disease: current status and future perspectives. Curr Opin Clin Nutr Metab Care 11:711–717

Download references

Acknowledgments

The authors thank the National Center for Health Statistics of the Centers for Disease Control and Prevention for sharing the data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lijun Li.

Ethics declarations

Conflict of Interest

None

Ethical Approval

NHANES was approved by the National Center for Health Statistics Research Ethics Review Board.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 43 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, L., Shao, F. & Li, L. Association of Copper and Zinc Intake with Inflammatory Bowel Disease and Fecal Incontinence Symptoms: Evidence from the National Health and Nutrition Examination Survey. Biol Trace Elem Res 199, 2543–2551 (2021). https://doi.org/10.1007/s12011-020-02390-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-020-02390-7

Keywords

Navigation